Multidimensional character of asthma severity in the EGEA study;Caractère multidimensionnel de la sévérité de l'asthme dans l'enquête EGEA

Revue des Maladies Respiratoires

Volumn 21, Issue 5 I, 2004, Pages 917-924

  Siroux, V ^a,b   Kauffmann, F ^a   Pison, C ^b   Pin, I ^b  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Asthma; Hospitalization; Methods; Severity; Ventilatory function

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 10644293988     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71473-4     Document Type: Article

References (44)

1. Stein RE, Gortmaker SL, Perrin EC, Perrin JM, Pless IB, Walker DK, Weitzman M: Severity of illness: concepts and measurements. Lancet 1987; 2: 1506-9.
2. Siroux V, Pin I, Pison C, Kauffmann F: Asthme sévère en population générale: définitions et prévalence. Rev Mal Respir 2004; 21: 961-9.
3. National Asthma Education and Prevention Program: Expert panel report 2. Guidelines for the diagnosis and management of asthma. July 1997, NIH publication no. 97-4051.
4. Global initiative for asthma: Global strategy for asthma management and prevention. NHLBI/WHO workshop report, january 1995; NIH publication no. 95-3659.
5. Global initiative for asthma: Global strategy for asthma management and prevention. NHLBI/WHO workshop Report, February 2002. NIH publication no. 02-3659.
6. Wijnhoven HA, Kriegsman DM, Hesselink AE, Penninx BW, de Haan M: Determinants of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life. Chest 2001; 119: 1034-42.
7. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
8. Bailey WC, Higgins DM, Richards BM, Richards JM, Jr: Asthma severity: a factor analytic investigation. Am J Med 1992; 93: 263-9.
9. Rabe KF, Vermeire PA, Soriano JB, Maier WC: Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-7.
10. Verini M, Rossi N, Dalfino T, Verrotti A, Di Gioacchino M, Chiarelli F: Lack of correlation between clinical patterns of asthma and airway obstruction. Allergy Asthma Proc 2001; 22: 297-302.
11. Teeter JG, Bleecker ER: Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998; 113: 272-7.
12. The ENFUMOSA study group: The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003; 22: 470-7.
13. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160: 1001-8.
14. Kauffmann F: Génétique des bronchopneumopathies obstructives chroniques. À la recherche de leur hété rogénéité. Bull Eur Physiopathol Respir 1984; 20: 163-210.
15. Romanet-Manent S, Charpin D, Magnan A, Lanteaume A, Vervloet D, and the EGEA cooperative group: Allergic vs nonallergic asthma: what makes the difference? Allergy 2002; 57: 607-13.
16. Kauffmann F, Dizier MH, Annesi-Maesano I, Bousquet J, Charpin D, Demenais F, Ecochard D, Feingold J, Gormand F, Grimfeld A, Lathrop M, Matran R, Neukirch F, Paty E, Pison C, Scheinmann P, Vervloet D, Lockhart A: Etude épidémiologique des facteurs génétiques et environnementaux de l'asthme, l'hyperréactivité bronchique et l'atopie (EGEA) - Protocole et biais de sélection potentiels. Rev Epidemiol Sante Publique 2001; 49: 343-56.
17. Kauffmann F, Dizier MH, on behalf of the EGEA cooperative group: EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) - design issues. Clin Exp Allergy 1995; 25: 19-22.
18. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F: Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J 2000; 15: 470-7.
19. Pin I, Siroux V, Cans C, Kauffmann F, Maccario J, Pison C, Dizier MH: Familial resemblance of asthma severity in the EGEA study. Am J Respir Crit Care Med 2002; 165: 185-9.
20. Kauffmann F, Annesi-Maesano I, Liard R, Paty E, Faraldo B, Neukirch F, Dizier MH: Construction et validation d'un questionnaire en épidé miologie respiratoire. L'exemple du questionnaire de l'étude épidémiologique des facteurs génétiques et environnementaux de l'asthme, l'hyperréactivité bronchique et l'atopie (EGEA). Rev Mal Respir 2002; 19: 323-33.
21. European Community Respiratory Health Survey: Anonymous. United Medical and Dental schools of Guy's ans St-Thomas's Hospitals, Department of Public Health Medicine. Protocol for the European Community Respiratory Health Survey. London, 1993.
22. Quanjer PH, Tammeling GJ: Summary of recommendations. In: Quanjer P.H. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19: 7-10.
23. Polgar G, Weng TR: The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis 1979; 120: 625-95.
24. Kauffmann F, Dizier MH, Pin I, Paty E, Gormand F, Vervloet D, Bousquet J, Neukirch F, Annesi I, Oryszczyn MP, Larhrop M, Demenais F, Lockhart A, Feingold J: Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med 1997; 156: S123-9.
25. Jolliffe IT: Principal Component Analysis. New York: Springer-Verlag, 1986.
26. Agresti A: Categorical data analysis. New york: Wiley, 1990.
27. Charpentier P, Aboiron H: Classification internationale des handicaps. Encycl Med Chir 2000; 26: 1-6.
28. Osborne ML, Vollmer WM, Pedula KL, Wilkins J, Buist AS, O'Hollaren M: Lack of correlarion of symptoms with specialist-assessed long-term asthma severity. Chest 1999; 115: 85-91.
29. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH: Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744-8.
30. Shingo S, Zhang J, Reiss TF: Correlation of airway obstruction and patienr-reported endpoints in clinical studies. Eur Respir J 2001; 17: 220-4.
31. Serra-Batlles J, Plaza V, Morejon E, Comelia A, Brugues J: Costs of asthma according to the degree of severity. Eur Respir J 1998; 12: 1322-6.
32. Miravitlles M, Vila S, Torrella M, Balcells E, Rodriguez-Frias F, de L, Jardi R, Vidal R: Influence of deficient alpha1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults. Respir Med 2002; 96: 186-92.
33. Ronchetti R, Indinnimeo L, Bonci E, Corrias A, Evans D, Hindi-Alexander M, Midulla F, Pulejo R, Villa MP: Asthma self-management programmes in a population of Italian children: a multicentric study. Italian Study Group on Asthma Self-Management Programmes. Eur Respir J 1997; 10: 1248-53.
34. Blanc PD, Jones M, Besson C, Katz P, Yelin E: Work disability among adults with asthma. Chest 1993; 104: 1371-7.
35. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A: Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002; 324: 763.
36. Chan-Yeung M, Manfreda J, Dimich-Ward H, Lam J, Ferguson A, Warren P, Simons E, Broder I, Chapman M, Platts-Mills T: Mite and cat allergen levels in homes and severity of asthma. Am J Respir Crit Care Med 1995; 152: 1805-11.
37. Hiltermann TJ, Stolk J, van der Zee SC, Brunekreef B, de Bruijne CR, Fischer PH, Ameling CB, Sterk PJ, Hiemstra PS, van Bree L: Asthma severity and susceptibility to air pollution. Eur Respir J 1998; 11: 686-93.
38. Eisner MD: Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma. Environ Health Perspect 2002; 110: 765-70.
39. Anderson HR, Butland BK, Strachan DP: Trends in prevalence and severity of childhood asthma. BMJ 1994; 308: 1600-4.
40. Weir TD, Mallek N, Sandford AJ, Bai TR, Awadh N, Fitzgerald JM, Cockcroft D, James A, Liggett SB, Pare PD: beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158: 787-91.
41. Burchard EG, Silverman EK, Rosenwasser LJ, Borish L, Yandava C, Pillari A, Weiss ST, Hasday J, Lilly CM, Ford JG, Drazen JM: Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med 1999; 160: 919-22.
42. Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F: Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J 2000; 16: 615-20.
43. Bel EH: Clinical phenotypes of asthma. Curr Opin Pulm Med 2004; 10: 44-50.
44. Siroux V, Curt F, Oryszczyn MP, Maccario J, Kauffmann F: Role of gender and hormone-related events on IgE, atopy and eosinophils in the EGEA study. J Allergy Clin Immunol 2004; 114: 491-8.